Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Supplementation With Clostridium Butyricum CBM588 in Patients Undergoing Pancreaticoduodenectomy for Periampullary Neoplasms: A Prospective Randomized Double-Blind Study

NCT07422103 is registered in ClinicalTrials.gov with Casa di Cura Dott. Pederzoli as lead sponsor.

NCT NCT07422103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07422103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Supplementation With Clostridium Butyricum CBM588 in Patients Undergoing Pancreaticoduodenectomy for Periampullary Neoplasms: A Prospective Randomized Double-Blind Study
Lead sponsor
Casa di Cura Dott. Pederzoli
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 15, 2026
Completion date
November 30, 2030
Enrollment
158 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cbm588, clostridium butyricum miyairi, gastrointestinal symptoms, pancreatic cancer, pancreatic diseases, pancreatoduodenectomy